Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion November 21, 2024
PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million November 12, 2024
The Board of Directors of DUG Foodtech has resolved on a directed set-off issue of approximately SEK 7 million November 8, 2024
The Board of Directors of Irisity AB (publ) has resolved on a previously announced rights issue of units of approximately SEK 70.6 million November 4, 2024
Berkshire Partners Announces Close of Fund XI with Approximately $7.8 Billion in Commitments November 2, 2024
NTT DATA Establishes Generative AI Talent Development Framework to Train Approximately 200,000 Employees Globally and Develop 30,000 Experts October 25, 2024
Stendörren completes a directed issue of 2,630,208 B shares, raising proceeds of approximately SEK 505 million October 23, 2024
Stendörren evaluates the conditions to carry out a directed share issue of B shares of approximately SEK 500 million October 23, 2024
The Board of Directors of Metacon has resolved on a rights issue of approximately SEK 138 million, conditional on the approval of the extraordinary general meeting October 16, 2024
